Senores Pharmaceuticals Re-Appoints Managing Director and Whole-Time Director for Three-Year Terms
Senores Pharmaceuticals Ltd 路 Change in Management 路 13 Oct 2026, 5:53 pm
Senores Pharmaceuticals Re-Appoints Managing Director and Whole-Time Director for Three-Year Terms The Board of Directors of Senores Pharmaceuticals Limited approved the re-appointment of Mr. Swapnil Jatinbhai Shah as Managing Director for a three-year term effective 15th Oct'26. Additionally, the Board approved the re-appointment of Mr. Chetan Bipinchandra Shah as Whole-Time Director for three consecutive years starting 10th Nov'26. Both directors are liable to retire by rotation, and the appointments are subject to shareholder approval via postal ballot. Neither director is related inter-se to any other board members or debarred by SEBI.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
